FENNEC PHARMACEUTICALS INC. Cash and Cash Equivalents, Period Increase (Decrease)
FENNEC PHARMACEUTICALS INC. (FENC) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$2.55 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-10
- FENNEC PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$2.55M.
- FENNEC PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$1.74M, a 109.39% decline year-over-year.
- FENNEC PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$1.12M.
- FENNEC PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was -$1.08M, a 115.46% decline year-over-year.
- FENNEC PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$5.48M, a 122.52% decline from fiscal 2017.
- FENNEC PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $24.33M, a 715.48% increase from fiscal 2016.
- FENNEC PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $2.98M.
- FENNEC PHARMACEUTICALS INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$1.36M, a 311.96% decline from fiscal 2014.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 181 month | Cash and Cash Equivalents, Period Increase (Decrease) 184 month | Cash and Cash Equivalents, Period Increase (Decrease) 187 month | Cash and Cash Equivalents, Period Increase (Decrease) 190 month | Cash and Cash Equivalents, Period Increase (Decrease) 193 month | Cash and Cash Equivalents, Period Increase (Decrease) 196 month | Cash and Cash Equivalents, Period Increase (Decrease) 199 month | Cash and Cash Equivalents, Period Increase (Decrease) 202 month | Cash and Cash Equivalents, Period Increase (Decrease) 205 month | Cash and Cash Equivalents, Period Increase (Decrease) 208 month | Cash and Cash Equivalents, Period Increase (Decrease) 211 month | Cash and Cash Equivalents, Period Increase (Decrease) 214 month | Cash and Cash Equivalents, Period Increase (Decrease) 217 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | -$2.55M 10-Q · filed 2019-05-10 | -$4.29M derived: sum of 2 quarters · filed 2019-05-10 | -$5.41M derived: sum of 3 quarters · filed 2019-05-10 | -$6.49M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||||||
| 2018-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | -$2.86M derived: sum of 2 quarters · filed 2019-03-15 | -$3.94M derived: sum of 3 quarters · filed 2019-03-15 | -$5.48M 10-K · filed 2019-03-15 | |||||||||||||
| 2018-09-30 | -$1.12M 10-Q · filed 2018-11-13 | -$2.19M derived: sum of 2 quarters · filed 2018-11-13 | -$3.74M 10-Q · filed 2018-11-13 | $14.84M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||||||
| 2018-06-30 | -$1.08M 10-Q · filed 2018-08-13 | -$2.62M 10-Q · filed 2018-08-13 | $15.95M derived: sum of 3 quarters · filed 2019-05-10 | $15.41M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||||||
| 2018-03-31 | -$1.54M 10-Q · filed 2019-05-10 | $17.03M derived: sum of 2 quarters · filed 2019-05-10 | $16.49M derived: sum of 3 quarters · filed 2019-05-10 | $23.47M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||||||
| 2017-12-31 | $18.57M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $18.03M derived: sum of 2 quarters · filed 2019-03-15 | $25.01M derived: sum of 3 quarters · filed 2019-03-15 | $24.33M 10-K · filed 2019-03-15 | |||||||||||||
| 2017-09-30 | -$544.00K 10-Q · filed 2018-11-13 | $6.44M derived: sum of 2 quarters · filed 2018-11-13 | $5.76M 10-Q · filed 2018-11-13 | $5.15M derived: sum of 4 quarters · filed 2018-11-13 | |||||||||||||
| 2017-06-30 | $6.98M 10-Q · filed 2018-08-13 | $6.31M 10-Q · filed 2018-08-13 | $5.70M derived: sum of 3 quarters · filed 2018-08-13 | $5.15M derived: sum of 4 quarters · filed 2018-08-13 | |||||||||||||
| 2017-03-31 | -$675.00K 10-Q · filed 2018-05-14 | -$1.29M derived: sum of 2 quarters · filed 2018-05-14 | -$1.83M derived: sum of 3 quarters · filed 2018-05-14 | $2.71M derived: sum of 4 quarters · filed 2018-05-14 | |||||||||||||
| 2016-12-31 | -$611.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | -$1.16M derived: sum of 2 quarters · filed 2018-03-28 | $3.38M derived: sum of 3 quarters · filed 2018-03-28 | $2.98M 10-K · filed 2018-03-28 | |||||||||||||
| 2016-09-30 | -$544.00K 10-Q · filed 2017-11-13 | $3.99M derived: sum of 2 quarters · filed 2017-11-13 | $3.60M 10-Q · filed 2017-11-13 | $3.17M derived: sum of 4 quarters · filed 2017-11-13 | |||||||||||||
| 2016-06-30 | $4.54M 10-Q · filed 2017-08-14 | $4.14M 10-Q · filed 2017-08-14 | $3.71M derived: sum of 3 quarters · filed 2017-08-14 | $3.23M derived: sum of 4 quarters · filed 2017-08-14 | |||||||||||||
| 2016-03-31 | -$397.00K 10-Q · filed 2017-05-12 | -$821.00K derived: sum of 2 quarters · filed 2017-05-12 | -$1.31M derived: sum of 3 quarters · filed 2017-05-12 | -$1.37M derived: sum of 4 quarters · filed 2017-05-12 | |||||||||||||
| 2015-12-31 | -$424.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | -$912.00K derived: sum of 2 quarters · filed 2017-03-29 | -$974.00K derived: sum of 3 quarters · filed 2017-03-29 | -$1.36M 10-K · filed 2017-03-29 | |||||||||||||
| 2015-09-30 | -$488.00K 10-Q · filed 2016-11-14 | -$550.00K derived: sum of 2 quarters · filed 2016-11-14 | -$941.00K 10-Q · filed 2016-11-14 | $773.00K derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||||
| 2015-06-30 | -$62.00K 10-Q · filed 2016-08-12 | -$453.00K 10-Q · filed 2016-08-12 | $1.26M derived: sum of 3 quarters · filed 2016-08-12 | $839.00K derived: sum of 4 quarters · filed 2016-08-12 | |||||||||||||
| 2015-03-31 | -$391.00K 10-Q · filed 2016-05-12 | $1.32M derived: sum of 2 quarters · filed 2016-05-12 | $901.00K derived: sum of 3 quarters · filed 2016-05-12 | $578.00K derived: sum of 4 quarters · filed 2016-05-12 | |||||||||||||
| 2014-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $1.29M derived: sum of 2 quarters · filed 2016-03-28 | $969.00K derived: sum of 3 quarters · filed 2016-03-28 | $644.00K 10-K · filed 2016-03-28 | |||||||||||||
| 2014-09-30 | -$422.00K 10-Q · filed 2015-11-12 | -$745.00K derived: sum of 2 quarters · filed 2015-11-12 | -$1.07M 10-Q · filed 2015-11-12 | $55.00K derived: sum of 4 quarters · filed 2015-11-12 | $593.00K 10-Q · filed 2014-11-13 | ||||||||||||
| 2014-06-30 | -$323.00K 10-Q · filed 2015-08-11 | -$648.00K 10-Q · filed 2015-08-11 | $477.00K derived: sum of 3 quarters · filed 2015-08-11 | $8.00K derived: sum of 4 quarters · filed 2015-08-11 | $1.01M 10-Q · filed 2014-08-11 | ||||||||||||
| 2014-03-31 | -$325.00K 10-Q · filed 2015-05-15 | $800.00K derived: sum of 2 quarters · filed 2015-05-15 | $331.00K derived: sum of 3 quarters · filed 2015-05-15 | -$558.00K derived: sum of 4 quarters · filed 2015-05-15 | $1.34M 10-Q · filed 2014-05-15 | ||||||||||||
| 2013-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $656.00K derived: sum of 2 quarters · filed 2015-03-31 | -$233.00K derived: sum of 3 quarters · filed 2015-03-31 | -$640.00K 10-K · filed 2015-03-31 | $1.66M 10-K · filed 2014-03-31 | ||||||||||||
| 2013-09-30 | -$469.00K 10-Q · filed 2014-11-13 | -$1.36M derived: sum of 2 quarters · filed 2014-11-13 | -$1.76M 10-Q · filed 2014-11-13 | -$2.32M derived: sum of 4 quarters · filed 2014-11-13 | $538.00K 10-Q · filed 2013-11-18 | ||||||||||||
| 2013-06-30 | -$889.00K 10-Q · filed 2014-08-11 | -$1.30M 10-Q · filed 2014-08-11 | -$1.85M derived: sum of 3 quarters · filed 2014-08-11 | -$2.58M derived: sum of 4 quarters · filed 2014-08-11 | $1.01M 10-Q · filed 2013-08-09 | ||||||||||||
| 2013-03-31 | -$407.00K 10-Q · filed 2014-05-15 | -$964.00K derived: sum of 2 quarters · filed 2014-05-15 | -$1.69M derived: sum of 3 quarters · filed 2014-05-15 | -$2.82M derived: sum of 4 quarters · filed 2014-05-15 | $1.90M 10-Q · filed 2013-05-13 | ||||||||||||
| 2012-12-31 | -$557.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$1.28M derived: sum of 2 quarters · filed 2014-03-31 | -$2.42M derived: sum of 3 quarters · filed 2014-03-31 | -$2.99M 10-K · filed 2014-03-31 | $2.30M 10-K · filed 2013-04-01 | ||||||||||||
| 2012-09-30 | -$726.00K 10-Q · filed 2013-11-18 | -$1.86M derived: sum of 2 quarters · filed 2013-11-18 | -$2.44M 10-Q · filed 2013-11-18 | -$3.31M derived: sum of 4 quarters · filed 2013-11-18 | $2.86M 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | -$1.13M 10-Q · filed 2013-08-09 | -$1.71M 10-Q · filed 2013-08-09 | -$2.59M derived: sum of 3 quarters · filed 2013-08-09 | -$3.22M derived: sum of 4 quarters · filed 2013-08-09 | $3.59M 10-Q · filed 2012-08-13 | ||||||||||||
| 2012-03-31 | -$578.00K 10-Q · filed 2013-05-13 | -$1.46M derived: sum of 2 quarters · filed 2013-05-13 | -$2.09M derived: sum of 3 quarters · filed 2013-05-13 | -$304.00K derived: sum of 4 quarters · filed 2013-05-13 | $4.72M 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | -$877.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | -$1.51M derived: sum of 2 quarters · filed 2013-04-01 | $274.00K derived: sum of 3 quarters · filed 2013-04-01 | -$650.00K 10-K · filed 2013-04-01 | $5.30M 10-K · filed 2012-03-27 | ||||||||||||
| 2011-09-30 | -$636.00K 10-Q · filed 2012-11-14 | $1.15M derived: sum of 2 quarters · filed 2012-11-14 | $227.00K 10-Q · filed 2012-11-14 | -$428.00K derived: sum of 4 quarters · filed 2012-11-14 | $6.17M 10-Q · filed 2011-11-14 | ||||||||||||
| 2011-06-30 | $1.79M 10-Q · filed 2012-08-13 | $882.00K 10-Q · filed 2012-08-13 | $208.00K derived: sum of 3 quarters · filed 2012-08-13 | -$342.00K derived: sum of 4 quarters · filed 2012-08-13 | |||||||||||||
| 2011-03-31 | -$924.00K 10-Q · filed 2012-05-15 | -$1.58M derived: sum of 2 quarters · filed 2012-05-15 | -$2.13M derived: sum of 3 quarters · filed 2012-05-15 | $4.67M derived: sum of 4 quarters · filed 2012-05-15 | |||||||||||||
| 2010-12-31 | -$655.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27 | -$1.21M derived: sum of 2 quarters · filed 2012-03-27 | $5.60M derived: sum of 3 quarters · filed 2012-03-27 | $5.26M 10-K · filed 2012-03-27 | |||||||||||||
| 2010-09-30 | -$550.00K 10-Q · filed 2011-11-14 | $6.25M derived: sum of 2 quarters · filed 2011-11-14 | $5.92M 10-Q · filed 2011-11-14 | ||||||||||||||
| 2010-06-30 | $6.80M 10-Q · filed 2011-08-15 | $6.47M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |